Mephedrone
| 4-MMC | |
|---|---|
| Salts [] | |
|---|---|
| Mephedrone hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 177.24 g/mol [1] |
| Appearance | Fine-white to off-white or slightly colored powder ... also found in tablet or capsule form [1] |
| Predicted LogP | 2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H15NO [1] |
| IUPAC name | 2-(methylamino)-1-(4-methylphenyl)propan-1-one [1] |
| SMILES | CC1=CC=C(C=C1)C(=O)C(C)NC [1] |
| InChI | InChI=1S/C11H15NO/c1-8-4-6-10(7-5-8)11(13)9(2)12-3/h4-7,9,12H,1-3H3 [1] |
| InChIKey | YELGFTGWJGBAQU-UHFFFAOYSA-N [1] |
| Dosing[] |
|---|
| Insufflated [] | |
|---|---|
| Light | ≤ 75.3 mg(1550x - 30.5%) |
| Common | 75.3 - 90 mg(1145x - 22.5%) |
| Strong | 90 - 110 mg(1169x - 23%) |
| Heavy | 110 - 130 mg(726x - 14.3%) |
| Extreme | 130 mg +(498x - 9.8%) |
| Intravenous [] | |
|---|---|
| Light | ≤ 47.6 mg(81x - 27.6%) |
| Common | 47.6 - 60 mg(94x - 32%) |
| Strong | 60 - 80 mg(56x - 19%) |
| Heavy | 80 - 100 mg(34x - 11.6%) |
| Extreme | 100 mg +(29x - 9.9%) |
| Oral [] | |
|---|---|
| Light | ≤ 173.4 mg(146x - 37.2%) |
| Common | 173.4 - 200 mg(69x - 17.6%) |
| Strong | 200 - 300 mg(91x - 23.2%) |
| Heavy | 300 - 367.7 mg(43x - 11%) |
| Extreme | 367.7 mg +(43x - 11%) |
| Intrarectal [] | |
|---|---|
| Light | ≤ 76.1 mg(13x - 36.1%) |
| Common | 76.1 - 98 mg(5x - 13.9%) |
| Strong | 98 - 121.3 mg(9x - 25%) |
| Heavy | 121.3 - 183.4 mg(2x - 5.6%) |
| Extreme | 183.4 mg +(7x - 19.4%) |
| Vaporized [] | |
|---|---|
| Light | ≤ 8 mg(4x - 36.4%) |
| Common | 8 - 9 mg(2x - 18.2%) |
| Strong | 9 - 11.5 mg(2x - 18.2%) |
| Heavy | 11.5 - 13 mg(2x - 18.2%) |
| Extreme | 13 mg +(1x - 9.1%) |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Mephedrone (also known as Mephedrone, 4-methylmethcathinone, Meow meow, 4-MMC, M-CAT, 4-methylephedrone, bk-4-methylmethamphetamine, β-keto-4-methylmethamphetamine, J2.756.280i or Chebi:59331) is a
Chemistry
Salts []
Mephedrone is typically found in the form of its hydrochloride salt.
Stereochemistry []
Mephedrone is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Subjective effects []
| Pilz / Mephedrone [] | |
|---|---|
Routes:
| |
| 0xea / Mephedrone [] | |
|---|---|
Routes:
| |
Legal status []
- Australia: Mephedrone is a S9 substance.
- Brazil: Mephedrone is a F2 substance.[3]
- Germany: Mephedrone is a Anlage I substance.
- United Kingdom: Mephedrone is a Class B substance.
- United States: Mephedrone is a Schedule I under the "Controlled Substances Act (CSA)".
- United Nations: Mephedrone is a Schedule II drug under the "Convention on Psychotropic Substances 1971".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 45266826, Mephedrone. Accessed April 15, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/45266826
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Mephedrone. UNII: 8BA8T27317. Global Substance Registration System. Accessed April 15, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/8BA8T27317
Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed April 15, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451